儿科药物坚持和家长的注意:来自综合索赔数据的证据
Josh Feng1, Matthew J Higgins2,3,4, Elena Patel1
1The University of Utah, Salt Lake City, Utah, USA.
Health economics
|November 15, 2025
概括
在COVID-19大流行期间,喘药物坚持显著下降,特别是在幼儿中. 父母的注意力影响了这些坚持的趋势,突出了改善儿科喘管理策略的需要.
科学领域:
- 公共卫生 公共卫生
- 儿科 儿科 儿科
- 医疗保健服务研究 医疗服务研究
背景情况:
- 随着COVID-19的流行,医疗保健的获取和患者的行为面临了前所未有的挑战.
- 坚持服用喘药物对于治疗喘和预防喘恶化至关重要,特别是在儿童群体中.
- 了解流行病对坚持的影响对于维持慢性疾病管理至关重要.
研究的目的:
- 分析美国在COVID-19大流行期间喘控制药物坚持的趋势.
- 调查儿童和成年人之间坚持改变的年龄特异性差异.
- 探索诸如家长的注意力等影响依从性下降的因素.
主要方法:
- 利用全面的美国药物索赔数据来追踪药物坚持.
- 分析了不同年龄组 (幼儿,老年儿童,成年人) 的坚持率.
- 根据大流行前的邮寄订单使用情况和家长脚本数据,检查了依从性的异质性.
主要成果:
- 在疫情期间,对喘控制药物的整体坚持下降.
- 到2020年年底,幼儿的坚持率大幅下降40%,在2020年底,幼儿的坚持率大幅下降.
- 年长的孩子表现出较少的负面反应,而成年人表现出积极的坚持趋势.
- 疫情前的邮购使用和家长脚本的数量与坚持变化相关,这表明家长关注的作用.
结论:
- 随着COVID-19大流行,喘药物治疗的坚持受到了负面影响,幼儿受到了最严重的影响.
- 在公共卫生危机期间,家长因素似乎在儿科执法中发挥着重要作用.
- 研究结果强调需要有针对性的干预措施,以支持儿童喘管理和坚持.
更多相关视频
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
13.9K
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.3K
相关概念视频
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
234
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
197
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
01:29Drug Dosing: Infants and Children
237
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
237
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
01:28Drug Therapy
236
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
236